Worldwide Allogeneic T cell therapies Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4355267
- 131 Pages
- March 2021
- Healthcare
Allogeneic t cell treatments depend upon a solitary source of cells for the treatment of various patients. in this, the cells are accumulated from the donor for the production of the master cell financial institution.
The master cell bank is made use of as the source for the development of cell population that is further refined based on the needs of the details treatment.
While the final cell people is after that made use of for the treatment of numerous patients. the allogeneic t cell treatments have different benefits such as the instant readiness of
The cryopreserved batches for the individual treatment, standardization of the car-t cell, time for cell alterations, the cooperation of car t cells routed against the diverse targets, redosing and reduced costs making use of an industrialized treatment.
Car-t and tcr-t treatments have actually already reinvented blood cancer cells therapy. researchers duke-nus medical college are checking out the capacity of turning this strategy for the therapy of coronavirus people.
Scientists likewise educated that these immunotherapies could additionally valuable in the therapy of sars-cov-2, the infection resulting in the present episode. numerous business are servicing cell treatments for coronavirus.
Allovir & baylor university of medicine are teamed up to create a cutting-edge treatment to deal with the coronavirus.
Allogeneic t cell therapies market: drivers and restraints:
Increasing cases of cancer cells and an increasing variety of individuals with failure reaction to varied therapies are experienced to increases the allogeneic t cell therapy market growth internationally.
In addition, increasing occurrence of cancer in geriatric & pediatric individuals is projected to lead to higher demand for an efficient as well as trusted therapy approach for the renovation of quality of patients lives.
Additionally, rising government tasks for boosting health care insurance coverage structure and advancement in research study & development tasks for allogeneic t cell therapy is fueling the advancement of the allogeneic t cell treatment market.
At the same time, negative effects connected to the allogeneic t cell therapy may cause cytokine release disorder & various other neurological disorders consisting of coma, seizures, ecstasy as well as hallucinations.
This variable is seen to limit the allogeneic t cell treatment market growth.
Allogeneic t cell therapies market: introduction
Cd19 target antigens are observed to hold the leading market share owing to the fact that end number of the business were capable to get their antigens authorized & thus, commercialized them.
Furthermore, the diagnostic centers sector held the largest share owing to the climbing research and also advancement tasks and the usage of crafted cell treatment in molecular diagnostics.
Nevertheless, the severe lymphoblastic leukaemia has a dominant market share as allogeneic t cell treatment supplies a restorative advantage for the clients that are experiencing the failure of traditional therapy.
Allogeneic t cell treatments market: local smart overview
Geographically, the allogeneic t cell therapies market is segregated right into seven regions viz. Asia pacific, the United States and Canada & Latin America, eastern Europe western Europe, Japan, & the center east and Africa.
The United States and Canada is expected to dominate the worldwide allogeneic t cell therapies market adhered to by Europe & Asia pacific. north America is anticipated to dominate the international allogeneic t cell treatments market as a result of the rising venture as well as study & development tasks for the improvement of hatred treatments in this area.
Meanwhile, Asia pacific is witnessed to reveal impressive developments over the scale timespan owing to the expanding variety of worldwide players teaming up equally as assembling agreements for allogeneic t cell treatments with neighborhood players in the area.
Allogeneic t cell treatments market: vital market participants
The secret participants operating in the international allogeneic t cell treatments market identified across the worth chain include
Autolus.
Trakcel
Tmunity therapeutics
Bellicum pharmaceuticals inc.
Sorrento therapeutics
Bluebird inc.
Minerva biotechnologies corporation
Kite pharma
Celgene company
Cellectis
Fortress biotech.
Promab biotechnologies
Immune therapies
Ziopharm oncology inc
Juno therapies
Novartis ag
Celyad
Eureka therapeutics inc.
Tilt biotherapeutics
Poseida therapies inc.
Meanwhile
The significant gamers are concentrating on the essential merging as well as safeguarding to upgrade their share in the around the world allogeneic t cell therapy market. as an example, in april 2018, pfizer, inc. noted a setup with allogene, to construct up an investigational car-t cell treatment for fulfilling deadly growth.
In january 2019, novartis proclaimed that they will obtain cellforcure with the goal that they can expand their cell and also top quality treatment. this securing will certainly aid the company with making their allogeneic t cell therapies therapy kymriah easily accessible for a big variety of clients around the world and will likewise aid them with boosting their constructing limit of cell as well as high quality treatments.
The report covers exhaust evaluation on:
Allogeneic t cell therapies market sections
Allogeneic t cell treatments market dynamics
Market dimension
Supply & need present trends/issues/challenges
Competition & companies involved
Innovation
Value chain
Regional evaluation consists of:
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, UK, Spain)
Eastern Europe (Poland, Russia)
Asia pacific (India, China ASEAN, Australia & New Zealand)
Japan
The center east and Africa (GCC Countries, s. Africa, northern Africa)
Record highlights:
Thorough review of the medical care market
Changing allogeneic t cell therapies market dynamics in the industry
Below the allogeneic t cell therapies -deepness market division
Historic, current, and forecasted market size in terms of volume and value
Listed below the allogeneic t cell treatments current sector patterns as well as growths
Affordable landscape
Methods of essential gamers and also items supplied
Possible and also specific niche sectors, geographical areas showing encouraging growth
A neutral viewpoint on market efficiency
Essential info for market gamers to maintain as well as enhance their market impact
Allogeneic t cell therapies market: segmentation:
The worldwide allogeneic t cell treatments market has been segregated based upon antigen kind, sign, end-user and geography.
By antigen kind:
Cd 19
Cd 20
Egfrvlll
Gd2
Cd22
Cd30
Cd33
Meso
Her1
Her2
Egfrvlll
By indicator:
Diffuse huge b-cell lymphoma
Several myeloma
Acute lymphoblastic leukemia
Persistent lymphocytic leukemia
Follicular lymphoma
Others
By end-user:
Research study institutes
Biotechnological & pharmaceutical organizations
Diagnostic facilities or laboratories
Academics or academic facilities
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Allogeneic T cell therapies by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Allogeneic T cell therapies Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Allogeneic T cell therapies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Allogeneic T cell therapies Production from 2014-2020
4.3.1.2 North America Allogeneic T cell therapies Consumption from 2014-2020
4.3.1.3 North America Allogeneic T cell therapies Import and Export from 2014-2020
4.3.1.4 North America Allogeneic T cell therapies Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Allogeneic T cell therapies Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Allogeneic T cell therapies Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Allogeneic T cell therapies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Allogeneic T cell therapies Production from 2014-2020
4.3.2.2 Europe Allogeneic T cell therapies Consumption from 2014-2020
4.3.2.3 Europe Allogeneic T cell therapies Import and Export from 2014-2020
4.3.2.4 Europe Allogeneic T cell therapies Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Allogeneic T cell therapies Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Allogeneic T cell therapies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Allogeneic T cell therapies Production from 2014-2020
4.3.3.2 Asia-Pacific Allogeneic T cell therapies Consumption from 2014-2020
4.3.3.3 Asia-Pacific Allogeneic T cell therapies Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Allogeneic T cell therapies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Allogeneic T cell therapies Production from 2014-2020
4.3.4.2 Latin America Allogeneic T cell therapies Consumption from 2014-2020
4.3.4.3 Latin America Allogeneic T cell therapies Import and Export from 2014-2020
4.3.4.4 Latin America Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Allogeneic T cell therapies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Allogeneic T cell therapies Production from 2014-2020
4.3.5.2 Middle East & Africa Allogeneic T cell therapies Consumption from 2014-2020
4.3.5.3 Middle East & Africa Allogeneic T cell therapies Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Allogeneic T cell therapies Market from 2020-2026
7.1 Future Forecast of Global Allogeneic T cell therapies Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Allogeneic T cell therapies Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Allogeneic T cell therapies Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
788 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Allogeneic T cell therapies Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Allogeneic T cell therapies Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Allogeneic T cell therapies
Figure Type 2 of Allogeneic T cell therapies
Figure Type 3 of Allogeneic T cell therapies
Table Global Allogeneic T cell therapies Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Allogeneic T cell therapies Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Allogeneic T cell therapies
Figure Application 2 of Allogeneic T cell therapies
Figure Application 3 of Allogeneic T cell therapies
Table Global Allogeneic T cell therapies Production Value ($) by Regions
Table Global Allogeneic T cell therapies Production Value Share by Regions
Table Global Allogeneic T cell therapies Production by Regions
Table Global Allogeneic T cell therapies Production Share by Regions
Table Global Allogeneic T cell therapies Consumption by Regions
Table Global Allogeneic T cell therapies Consumption Share by Regions
Figure North America Allogeneic T cell therapies Production and Growth Rate from 2014-2020
Figure North America Allogeneic T cell therapies Consumption and Growth Rate from 2014-2020
Table North America Allogeneic T cell therapies Import and Export from 2014-2020
Table North America Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
Table North America Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
Table North America Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
Figure Europe Allogeneic T cell therapies Production and Growth Rate from 2014-2020
Figure Europe Allogeneic T cell therapies Consumption and Growth Rate from 2014-2020
Table Europe Allogeneic T cell therapies Import and Export from 2014-2020
Table Europe Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
Table Europe Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
Table Europe Allogeneic T cell therapies Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Allogeneic T cell therapies Production and Growth Rate from 2014-2020
Figure Asia-Pacific Allogeneic T cell therapies Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Allogeneic T cell therapies Import and Export from 2014-2020
Table Asia-Pacific Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
Figure Latin America Allogeneic T cell therapies Production and Growth Rate from 2014-2020
Figure Latin America Allogeneic T cell therapies Consumption and Growth Rate from 2014-2020
Table Latin America Allogeneic T cell therapies Import and Export from 2014-2020
Table Latin America Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Allogeneic T cell therapies Production and Growth Rate from 2014-2020
Figure Middle East & Africa Allogeneic T cell therapies Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Allogeneic T cell therapies Import and Export from 2014-2020
Table Middle East & Africa Allogeneic T cell therapies Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Allogeneic T cell therapies Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Allogeneic T cell therapies Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Allogeneic T cell therapies Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Allogeneic T cell therapies Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Allogeneic T cell therapies Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Allogeneic T cell therapies Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Allogeneic T cell therapies Production and Growth Rate Forecast by Types (2020-2026)
Table Global Allogeneic T cell therapies Consumption and Growth Rate Forecast by End-User/Applications (2020-2805)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
